Navigation Links
A cautionary tale on genome-sequencing diagnostics for rare diseases

LA JOLLA, Calif., May 10, 2013 Children born with rare, inherited conditions known as Congenital Disorders of Glycosylation, or CDG, have mutations in one of the many enzymes the body uses to decorate its proteins and cells with sugars. Properly diagnosing a child with CDG and pinpointing the exact sugar gene that's mutated can be a huge relief for parentsthey better understand what they're dealing with and doctors can sometimes use that information to develop a therapeutic approach. Whole-exome sequencing, an abbreviated form of whole-genome sequencing, is increasingly used as a diagnostic for CDG.

But researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) recently discovered three children with CDG who are mosaicsonly some cells in some tissues have the mutation. For that reason, standard exome sequencing initially missed their mutations, highlighting the technique's diagnostic limitations in some rare cases. These findings were published April 4 in the American Journal of Human Genetics.

"This study was one surprise after another," said Hudson Freeze, Ph.D., director of Sanford-Burnham's Genetic Disease Program and senior author of the study. "What we learned is that you have to be carefulyou can't simply trust that you'll get all the answers from gene sequencing alone."

Searching for a rare disease mutation

Complicated arrangements of sugar molecules decorate almost every protein and cell in the body. These sugars are crucial for cellular growth, communication, and many other processes. As a result of a mutation in an enzyme that assembles these sugars, children with CDG experience a wide variety of symptoms, including intellectual disability, digestive problems, seizures, and low blood sugar.

To diagnose CDG, researchers will test the sugar arrangements on a common protein called transferrin. Increasingly, they'll also look for known CDG-related mutations by whole-exome sequencing, a technique that sequences only the small portion of the genome that encodes proteins. The patients are typically three to five years old.

A cautionary tale for genomic diagnostics

In this study, the researchers observed different proportions and representations of sugar arrangements depending on which tissues were examined. In other words, these children have the first demonstrated cases of CDG "mosaicism"their mutations only appear in some cell types throughout the body, not all. As a result, the usual diagnostic tests, like whole-exome sequencing, missed the mutations. It was only when Freeze's team took a closer look, examining proteins by hand using biochemical methods, did they identify the CDG mutations in these three children.

The team then went back to the three original children and examined their transferrin again. Surprisingly, these readings, which had previously shown abnormalities, had become normal. Freeze and his team believe this is because mutated cells in the children's livers died and were replaced by normal cells over time.

"If the transferrin test hadn't been performed early on for these children, we never would've picked up these cases of CDG. We got lucky in this case, but it just shows that we can't rely on any one test by itself in isolation," Freeze said.


Contact: Patrick Bartosch
Sanford-Burnham Medical Research Institute

Related medicine news :

1. Supplements and cancer prevention: A cautionary tale
2. BIDMC and Diagnostics For All create first low-cost, paper-based, point of care liver function test
3. Canada In Vitro Diagnostics Market Analysis and Forecasts to 2017 in New Research Report at
4. Mayo Clinic and SV Bio enter strategic relationship on genome diagnostics and interpretation
5. Diagnostic Marketing Association Names Siemens Healthcare Diagnostics its 2012 Marketer of the Year
6. Advanced Mold Diagnostics Receives Angie's List Super Service Award for 4th Straight Year
7. ORNLs awake imaging device moves diagnostics field forward
8. Penn Medicines new center for personalized diagnostics unlocks cancers secrets
9. Expert Panel to Discuss Perspectives on Evaluating Novel Diagnostics for Reimbursement at 2013 Next Generation Dx Summit In Washington, DC
10. AstraZeneca and DNDi to collaborate on drug screening for neglected tropical diseases
11. Range of diagnostic spinal fluid tests needed to differentiate concurrent brain diseases
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... ... of a new PDF automation tool to batch conversions of CAD drawings, ... with 100% document fidelity. , CADConverter eliminates the complexity requirement of specialized applications ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... and development solutions for drugs, biologics, consumer health and animal health products, today ... and will lead a new, dedicated global team of drug development and technology ...
(Date:10/12/2015)... ... October 13, 2015 , ... North American Tool Corporation has ... 2015 IBC National Meeting in Rosemont, IL on October 4th. , ... standards of excellence that customers have come to expect from members of IBC’s marketing ...
(Date:10/12/2015)... ... , ... Amerec , a leader in the steam and sauna industry, ... be displaying custom sauna and steam room solutions at the ISPA Conference & Expo ... customers, SpaEquip is recognized for their ability to assist in the design and implementation ...
(Date:10/12/2015)... AL (PRWEB) , ... October 12, 2015 , ... American ... continues to expand its footprint by opening its 151st medical center. Located at 606A ... , “We’re excited to continue fulfilling our mission of making quality health care ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... , Oct. 13, 2015  Asterias Biotherapeutics, ... with the UK-based Cell Therapy Catapult to advance ... Asterias, allogeneic dendritic cell immunotherapy. Under the agreement, ... manufacturing processes for AST-VAC2 to support advanced clinical ... --> --> The Cell ...
(Date:10/12/2015)... , Oct. 12, 2015 Given ... it is quite challenging to deliver an ophthalmic drug effectively ... overcome for a successful ocular drug delivery. These include dilution ... the lymphatic system of conjunctiva and drug permeation issues with ... the drug, in topical eye drops, is lost due to ...
(Date:10/12/2015)... Use this report to: - Learn about ... medical membrane devices market. - Analyze the present and ... membrane devices market including hemodialyzers, membrane oxygenators, intravenous infusion ... - Gain information on newly approved products, recalls and ... this report to: - Learn about the performance, the ...
Breaking Medicine Technology: